期刊文献+

心脉隆注射液治疗老年急性心肌梗死后心力衰竭的可行性探讨 被引量:1

To Investigate the Feasibility of Xinmailong Injection in the Treatment of Heart Failure in Elderly Patients With Acute Myocardial Infarction
下载PDF
导出
摘要 目的分析心脉隆注射液治疗老年急性心肌梗死后心力衰竭的可行性。方法选取2014年1月—2017年5月40例老年急性心肌梗死后心力衰竭患者为研究对象,所有患者的心功能分级为Ⅱ~Ⅳ级,均采用心脉隆注射液进行治疗,对其治疗前后的心功能情况、B型脑钠肽、左室射血分数进行对比分析。结果相对于治疗前,患者治疗后的心功能、B型脑钠肽降低,左室内径减小,6 min步行距离、左室射血分数(LVEF)提高,组内对比差异有统计学意义(P<0.05)。结论心脉隆注射液治疗老年急性心肌梗死后心力衰竭的可行性强。 Objective To analyse the feasibility of Xinmailong injection on heart failure in elderly patients after acute myocardial infarction.Methods From January 2014 to May 2017,40 elderly patients with heart failure after acute myocardial infarction were selected as the subjects,cardiac function of all patients was graded from Ⅱ to Ⅳ grade,use of xinmailong injection for treatment,cardiac function,type B brain natriuretic peptide and left ventricular ejection fraction were compared before and after treatment.Results Relative to pre-treatment,cardiac function and type B brain natriuretic peptide decreased after treatment,decreased left ventricular diameter,6 min walking distance and left ventricular ejection fraction(LVEF) improved,the difference between groups was statistically significant(P〈0.05).Conclusion Xinmailong injection in treatment of elderly patients with acute heart failure after myocardial infarction is feasible.
作者 周文君
出处 《中国继续医学教育》 2017年第20期175-177,共3页 China Continuing Medical Education
关键词 心脉隆注射液 老年急性心肌梗死 心力衰竭 可行性 xinmailong injection acute myocardial infarction heart failure feasibility
  • 相关文献

参考文献8

二级参考文献64

  • 1余国膺.欧洲心脏学会修订心力衰竭指南[J].中国心脏起搏与心电生理杂志,2005,19(4):315-315. 被引量:4
  • 2程丽娟,富路.急性心肌梗死的早期诊断生化标志物[J].心血管病学进展,2006,27(1):67-69. 被引量:24
  • 3Sato Y, Fujiwara H, Takatsu Y. Cardiac troponin and heart failure in the era of high - sensitivity assays [J]. J Cardiol, 2012, 60 (3) : 160 - 167.
  • 4Body R, Carley S, McDoweU G, ct al. Rapid exclusion of acute myo- cardial itffarction in patients with undetectable troponin using a high - sensitivity assay [J]. J Am Coil Cardiol, 2011, 58 (13) : 1332 - 1339.
  • 5Metra M, Bettari L, Pagani F, et al. Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their de- tection and release during hospitalization [J]. Clin Res Cardiol, 2012, 101 (8): 663-672.
  • 6de Antonio M, Lupon J, Galan A, et al. Combined use of high - sen- sitivity cardiac treponin T and N - terminal pm - B type natriuretic pep- tide improves measurements of performance over established mortality risk factors in chronic heart failure [J]. Am Heart J, 2012, 163 (5) :821 -828.
  • 7Pascual - Figal DA, Casas T, Ordonez - Llanos J, et al. Highly sensi- tive troponin T for risk stratification of acutely destabilized heart failure [J]. Am HeartJ, 2012, 163 (6): 1002-1010.
  • 8Melki D, Lind S, Agewall S, et al. Prognostic value of combining high sensitive troponin T and N - terminal pro B - type natriuretic pep- tide in chest pain patients with no persistent ST- elevation [ J]. Clin Chim Acta, 2012, 413 (9/10): 933-937.
  • 9Jungbauer CG, Riedlinger J, Buchner S, et al. High - senstive tro- ponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis indepently from N - terminal pro- b- type natricuretic peptide [ J]. Clin Chem Lab Med, 2011, 49 (11): 1899 -1906.
  • 10Petrovic D, Obrenovic R, Stojimirovic B. Cm'diac troponins and left ventricular hypertrophy in hemodialysis patients [ J ]. Clin Lab, 2008, 54 (5/6): 145-152.

共引文献270

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部